Clinical Trials Directory

Trials / Unknown

UnknownNCT01227122

NGAL Predictive Value of Acute Kidney Failure After Cardiac Surgery in Patients With Preoperative Chronic Kidney Failure

Plasmatic Level of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Predictive Marker of Acute Kidney Failure in Patients With Preoperative Chronic Kidney Failure Undergoing Cardiac Surgery.

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Hopital Jean Minjoz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary endpoint: To evaluate predictive value of plasmatic levels of Neutrophil Gelatinase Associated Lipocalin (NGAL) to reveal acute kidney failure after cardiac surgery in patients with preoperative chronic kidney failure Secondary endpoint is to obtain threshold values of NGAL.

Detailed description

(N/A)

Conditions

Timeline

Start date
2010-08-01
Primary completion
2013-07-01
Completion
2013-09-01
First posted
2010-10-25
Last updated
2013-03-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01227122. Inclusion in this directory is not an endorsement.